Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today ...

In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction ...

Unlocking the secrets of luxury! 🚗✨ Discover how the ultra-wealthy transform their humble garages into stunning art ...

DAN POWERS Discussing difficult, complex, or controversial current events can be viewed as a minefield to be avoided at all ...

Nick Fenton’s love for music took him from splicing tape to spinning vinyl, now deejaying and running cabins with his wife in ...

A British artist has recreated the Mona Lisa using 100 iPhones after his Louvre visit was ruined by selfie-takers. Imbue, from Birmingham, laser-printed the image onto panels inside phone cases to ...

Bypassing the endless figuration-versus-abstraction debate, a trend in blurred painting techniques has emerged. In these ...

Knowable Magazine reports on attosecond science, revealing how scientists study atomic interactions at unbelievable speeds to ...

Diffusion-based molecular communication (MC) suffers from stochastic propagation, inter-symbol interference (ISI), and fast microfluidic variations. We present ART-Rx, an adaptive threshold receiver ...

The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.

Background: Molecular profiling is standard-of-care in metastatic NSCLC and increasingly important in earlier stages as personalized approaches arise. The role of adjuvant radiotherapy (ART) in ...